Email updates

Keep up to date with the latest news and content from Lipids in Health and Disease and BioMed Central.

Open Access Highly Accessed Research

The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study

Julius E Oben*, Judith L Ngondi, Claudia N Momo, Gabriel A Agbor and Caroline S Makamto Sobgui

Lipids in Health and Disease 2008, 7:12  doi:10.1186/1476-511X-7-12

PubMed Commons is an experimental system of commenting on PubMed abstracts, introduced in October 2013. Comments are displayed on the abstract page, but during the initial closed pilot, only registered users can read or post comments. Any researcher who is listed as an author of an article indexed by PubMed is entitled to participate in the pilot. If you would like to participate and need an invitation, please email info@biomedcentral.com, giving the PubMed ID of an article on which you are an author. For more information, see the PubMed Commons FAQ.

Cissus quadrangularis, fat loss and competing interests

Anssi Manninen   (2008-05-07 19:04)  Manninen Nutraceuticals Oy email

The lead author of this study has a patent on Cissus quadrangularis as a fat loss agent. A competing interest exists when professional judgement concerning a primary interest may be influenced by a secondary interest (e.g., financial gain). While there is nothing inherently unethical about a competing interest, they should be acknowledged and openly stated.

Anssi Manninen

Manninen Nutraceuticals Oy

Oulu, Finland

Competing interests

None.

top

Post a comment